Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian L Wiens

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Biopharmaceutical Statistics|April 26, 2011
Multiple testing procedures in two pivotal clinical trials for approval of a new pharmaceutical productBrian L Wiens
Pharmaceutical Statistics|November 28, 2006
Randomization as a basis for inference in noninferiority trialsBrian L Wiens
Journal of Biopharmaceutical Statistics|May 6, 2003
Assessing the impact of endpoint shopping on power in confirmatory clinical trialsBrian L Wiens
Controlled Clinical Trials|February 20, 2002
Choosing an equivalence limit for noninferiority or equivalence studiesBrian L Wiens
Clinical Trials (London, England)|February 26, 2026
Comment on: Shaping the future of clinical trials through strategic foresightBrian L Wiens
Journal of Biopharmaceutical Statistics|October 25, 2017
Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trialsBrian L Wiens
Statistics in Biopharmaceutical Research|June 30, 2021
The Impact of Major Events on Ongoing Noninferiority Trials, With Application to COVID-19Brian L Wiens, Ilya Lipkovich
Clinical Trials (London, England)|August 24, 2007
The role of intention to treat in analysis of noninferiority studiesBrian L Wiens, William Zhao
Journal of Biopharmaceutical Statistics|November 11, 2005
The fallback procedure for evaluating a single family of hypothesesBrian L Wiens, Alexei Dmitrienko
Journal of Biopharmaceutical Statistics|March 15, 2003
Testing for interaction in studies of noninferiorityBrian L Wiens, Joseph F Heyse
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|April 26, 2011
Multiple testing procedures in two pivotal clinical trials for approval of a new pharmaceutical productBrian L Wiens
Pharmaceutical Statistics|November 28, 2006
Randomization as a basis for inference in noninferiority trialsBrian L Wiens
Journal of Biopharmaceutical Statistics|May 6, 2003
Assessing the impact of endpoint shopping on power in confirmatory clinical trialsBrian L Wiens
Controlled Clinical Trials|February 20, 2002
Choosing an equivalence limit for noninferiority or equivalence studiesBrian L Wiens
Clinical Trials (London, England)|February 26, 2026
Comment on: Shaping the future of clinical trials through strategic foresightBrian L Wiens
Journal of Biopharmaceutical Statistics|October 25, 2017
Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trialsBrian L Wiens
Statistics in Biopharmaceutical Research|June 30, 2021
The Impact of Major Events on Ongoing Noninferiority Trials, With Application to COVID-19Brian L Wiens, Ilya Lipkovich
Clinical Trials (London, England)|August 24, 2007
The role of intention to treat in analysis of noninferiority studiesBrian L Wiens, William Zhao
Journal of Biopharmaceutical Statistics|November 11, 2005
The fallback procedure for evaluating a single family of hypothesesBrian L Wiens, Alexei Dmitrienko
Journal of Biopharmaceutical Statistics|March 15, 2003
Testing for interaction in studies of noninferiorityBrian L Wiens, Joseph F Heyse
Pageof 3